Literature DB >> 29067686

Association between γ marker, human leucocyte antigens and killer immunoglobulin-like receptors and the natural course of human cytomegalovirus infection: a pilot study performed in a Sicilian population.

Danilo Di Bona1, Giulia Accardi2, Anna Aiello2, Massimo Bilancia3, Giuseppina Candore2, Claudia Colomba4, Calogero Caruso2, Giovanni Duro5, Caterina M Gambino2, Luigi Macchia1, Janardan P Pandey6.   

Abstract

Natural killer (NK) cells provide a major defence against human cytomegalovirus (HCMV) infection through the interaction of their surface receptors, including the activating and inhibitory killer immunoglobulin-like receptors (KIRs), and human leucocyte antigen (HLA) class I molecules. Also γ marker (GM) allotypes, able to influence the NK antibody-dependent cell-mediated cytotoxicity, appear to be involved in the immunological control of virus infections, including HCMV. In some cases, their contribution requires epistatic interaction with other genes of the immune system, such as HLA. In the present report, with the aim of gaining insight into the immune mechanisms controlling HCMV, we have studied the possible associations among humoral and NK responses, and HCMV infections. In a previous study we assessed whether the KIR and HLA repertoire might influence the risk of developing symptomatic (n = 60) or asymptomatic (n = 60) disease after primary HCMV infection in the immunocompetent host. In the present study, the immunocompetent patients with primary symptomatic HCMV infection were genotyped for GM3/17 and GM23 allotypes, along with the 60 participants with a previous asymptomatic infection as controls. Notwithstanding the presence of missing data record, advanced missing data recovery techniques were able to show that individuals carrying the GM23 allotypes, both homozygous and heterozygous, GM17/17, HLA-C2 and Bw4T KIR-ligand groups are associated with the risk of developing symptomatic infection. Our findings on the role of both cellular and humoral immunity in the control of HCMV infection should be of value in guiding efforts to reduce HCMV-associated health complications in the elderly, including immunosenescence, and in transplantation.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  antibodies; human cytomegalovirus; human leucocyte antigen; killer immunoglobulin-like receptor; natural killer; γ marker

Mesh:

Substances:

Year:  2017        PMID: 29067686      PMCID: PMC5838424          DOI: 10.1111/imm.12855

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  30 in total

1.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

2.  The herpes simplex virus type 1 Fc receptor discriminates between IgG1 allotypes.

Authors:  A Atherton; K L Armour; S Bell; A C Minson; M R Clark
Journal:  Eur J Immunol       Date:  2000-09       Impact factor: 5.532

3.  The decoy Fcγ receptor encoded by the cytomegalovirus UL119-UL118 gene has differential affinity to IgG proteins expressing different GM allotypes.

Authors:  Janardan P Pandey; Aryan M Namboodiri; Faisal F Radwan; Paul J Nietert
Journal:  Hum Immunol       Date:  2015-09-14       Impact factor: 2.850

4.  Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs.

Authors:  Ramazan Atalay; Albert Zimmermann; Markus Wagner; Eva Borst; Christine Benz; Martin Messerle; Hartmut Hengel
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

5.  Interactive effects of immunoglobulin gamma and human leucocyte antigen genotypes on clearance and persistence of infection with hepatitis C virus.

Authors:  J P Pandey; M A Montes-Cano; J Aguilar-Reina; M F Gonzalez-Escribano
Journal:  Clin Exp Immunol       Date:  2007-10-09       Impact factor: 4.330

Review 6.  Modulation of natural killer cells by human cytomegalovirus.

Authors:  Gavin W G Wilkinson; Peter Tomasec; Richard J Stanton; Melanie Armstrong; Virginie Prod'homme; Rebecca Aicheler; Brian P McSharry; Carole R Rickards; Daniel Cochrane; Sian Llewellyn-Lacey; Eddie C Y Wang; Cora A Griffin; Andrew J Davison
Journal:  J Clin Virol       Date:  2008-03       Impact factor: 3.168

7.  HLA and killer cell immunoglobulin-like receptors influence the natural course of CMV infection.

Authors:  Danilo Di Bona; Valeria Scafidi; Antonella Plaia; Claudia Colomba; Domenico Nuzzo; Cecilia Occhino; Antonino Tuttolomondo; Giovanni Giammanco; Simona De Grazia; Giuseppe Montalto; Giovanni Duro; Marco Cippitelli; Calogero Caruso
Journal:  J Infect Dis       Date:  2014-04-15       Impact factor: 5.226

8.  Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity.

Authors:  Zeguang Wu; Christian Sinzger; Giada Frascaroli; Johanna Reichel; Carina Bayer; Li Wang; Reinhold Schirmbeck; Thomas Mertens
Journal:  J Virol       Date:  2013-05-01       Impact factor: 5.103

9.  CMV and Immunosenescence: from basics to clinics.

Authors:  Rafael Solana; Raquel Tarazona; Allison E Aiello; Arne N Akbar; Victor Appay; Mark Beswick; Jos A Bosch; Carmen Campos; Sara Cantisán; Luka Cicin-Sain; Evelyna Derhovanessian; Sara Ferrando-Martínez; Daniela Frasca; Tamas Fulöp; Sheila Govind; Beatrix Grubeck-Loebenstein; Ann Hill; Mikko Hurme; Florian Kern; Anis Larbi; Miguel López-Botet; Andrea B Maier; Janet E McElhaney; Paul Moss; Elissaveta Naumova; Janko Nikolich-Zugich; Alejandra Pera; Jerrald L Rector; Natalie Riddell; Beatriz Sanchez-Correa; Paolo Sansoni; Delphine Sauce; Rene van Lier; George C Wang; Mark R Wills; Maciej Zieliński; Graham Pawelec
Journal:  Immun Ageing       Date:  2012-10-31       Impact factor: 6.400

Review 10.  Controlling cytomegalovirus: helping the immune system take the lead.

Authors:  Patrick J Hanley; Catherine M Bollard
Journal:  Viruses       Date:  2014-05-27       Impact factor: 5.048

View more
  9 in total

1.  The immunoglobulin γ marker 17 allotype and KIR/HLA genes prevent the development of chronic hepatitis B in humans.

Authors:  Danilo Di Bona; Janardan P Pandey; Anna Aiello; Massimo Bilancia; Giuseppina Candore; Calogero Caruso; Claudia Colomba; Giovanni Duro; Mattia Emanuela Ligotti; Luigi Macchia; Sergio Rizzo; Giulia Accardi
Journal:  Immunology       Date:  2019-11-12       Impact factor: 7.397

2.  Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.

Authors:  Dominika Deborska-Materkowska; Agnieszka Perkowska-Ptasinska; Anna Sadowska-Jakubowicz; Jolanta Gozdowska; Michał Ciszek; Joanna Pazik; Agata Ostaszewska; Maciej Kosieradzki; Jacek Nowak; Magdalena Durlik
Journal:  Int J Mol Sci       Date:  2019-01-28       Impact factor: 5.923

3.  Deciphering the Potential Coding of Human Cytomegalovirus: New Predicted Transmembrane Proteome.

Authors:  Francisco J Mancebo; Marcos Parras-Moltó; Estéfani García-Ríos; Pilar Pérez-Romero
Journal:  Int J Mol Sci       Date:  2022-03-02       Impact factor: 5.923

Review 4.  Anti-Cytomegalovirus Therapy: Whether and When to Initiate, Those Are the Questions.

Authors:  Yumi Aoyama; Seiko Sugiyama; Takenobu Yamamoto
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-27

5.  Association of immunoglobulin GM allotypes with longevity in long-living individuals from Southern Italy.

Authors:  Annibale A Puca; Anna Ferrario; Anna Maciag; Giulia Accardi; Anna Aiello; Caterina Maria Gambino; Giuseppina Candore; Calogero Caruso; Aryan M Namboodiri; Janardan P Pandey
Journal:  Immun Ageing       Date:  2018-11-06       Impact factor: 6.400

6.  Genetics of exceptional longevity: possible role of GM allotypes.

Authors:  Calogero Caruso; Janardan P Pandey; Annibale A Puca
Journal:  Immun Ageing       Date:  2018-11-06       Impact factor: 6.400

7.  Multiple-Strain Infections of Human Cytomegalovirus With High Genomic Diversity Are Common in Breast Milk From Human Immunodeficiency Virus-Infected Women in Zambia.

Authors:  Nicolás M Suárez; Kunda G Musonda; Eric Escriva; Margaret Njenga; Anthony Agbueze; Salvatore Camiolo; Andrew J Davison; Ursula A Gompels
Journal:  J Infect Dis       Date:  2019-07-31       Impact factor: 5.226

Review 8.  Potential Impact of Human Cytomegalovirus Infection on Immunity to Ovarian Tumours and Cancer Progression.

Authors:  Momodou Cox; Apriliana E R Kartikasari; Paul R Gorry; Katie L Flanagan; Magdalena Plebanski
Journal:  Biomedicines       Date:  2021-03-30

Review 9.  Cytomegalovirus as an Uninvited Guest in the Response to Vaccines in People Living with HIV.

Authors:  Léna Royston; Stéphane Isnard; John Lin; Jean-Pierre Routy
Journal:  Viruses       Date:  2021-06-29       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.